No Data
No Data
JMP Securities Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $26
Robust Growth and Strategic Expansion Drive 'Buy' Rating for Privia Health Group
Privia Health Q3 Adjusted EPS, Revenue Increase
Privia Health | 10-Q: Quarterly report
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cross Country Healthcare (CCRN), CVS Health (CVS) and Privia Health Group (PRVA)
Express News | Privia Health Gr Expects FY24 Revenue at High End of Prior Guidance Range of $1.600-$1.675B Vs. Est. $1.83B
No Data
No Data